Neurocrine (NBIX) Ownership - Who Owns Neurocrine?

1,598 Followers

Neurocrine (NBIX) Ownership Overview

1.14% Insiders

26.31% Mutual Funds

21.99% Other Institutional Investors

30.08% ETFs

20.48% Public Companies and

Individual Investors

The ownership structure of Neurocrine (NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 78.39% of the company’s stock is owned by Institutional Investors, 1.14% is owned by Insiders, and 20.48% is owned by Public Companies and Individual Investors.

The ownership structure of Neurocrine (NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 48.30% of the company’s stock is owned by Institutional Investors, 1.14% is owned by Insiders, and 30.08% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Dodge & Cox	xxxxxxxxxxxxx	$719437014
Mar 31, 2024	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$19516095
Mar 31, 2024	Primecap Management Co	xxxxxxxxxxxxx	$65387832
Mar 31, 2024	Fisher Asset Management Llc	xxxxxxxxxxxxx	$16102053

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	11,820,925	Institution	11.76%	1,871,134,218
	8,678,397	Institution	8.63%	1,373,703,461
	7,925,651	Institution	7.88%	1,254,551,297
John A. Gunn	5,461,037	Institution	5.43%	864,427,547
	4,419,163	Institution	4.39%	699,509,311
	2,668,106	Institution	2.65%	422,334,499
	1,378,515	Institution	1.37%	218,205,139
	1,323,361	Institution	1.32%	209,474,813
	1,207,253	Institution	1.20%	191,096,077
	993,953	Institution	0.99%	157,332,820

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
7,925,651	Institution	7.88%	1,254,551,297
4,419,163	Institution	4.39%	699,509,311
1,323,361	Institution	1.32%	209,474,813
1,207,253	Institution	1.20%	191,096,077
993,953	Institution	0.99%	157,332,820
925,683	Institution	0.92%	146,526,362
711,083	Institution	0.71%	112,557,328
624,504	Institution	0.62%	98,852,738
540,194	Institution	0.54%	85,507,308
483,344	Institution	0.48%	76,508,522

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core S&P Mid-Cap ETF	3,481,983	Institution	3.46%	551,163,089
Vanguard Total Stock Market ETF	3,195,214	Institution	3.18%	505,802,376
iShares S&P Mid-Cap ETF CDI	3,000,296	Institution	2.98%	285,478,164
Vanguard Small-Cap ETF	2,309,376	Institution	2.30%	365,574,221
Vanguard Small-Cap Growth ETF	1,299,435	Institution	1.29%	205,700,561
Vanguard Extended Market ETF	1,134,904	Institution	1.13%	179,655,303
SPDR S&P Midcap 400 ETF Trust	755,397	Institution	0.75%	119,571,791
SPDR S&P BIOTECH ETF	736,290	Institution	0.73%	117,070,110
iShares Biotechnology ETF	715,109	Institution	0.71%	113,194,604
iShares S&P Mid-Cap 400 Growth ETF	619,593	Institution	0.62%	98,075,376

FAQ

Who Owns Neurocrine Biosciences (NBIX)?

According to the latest TipRanks data, approximately 21.99% of the company's stock is held by institutional investors, 1.14% is held by insiders, and 20.48% is held by retail investors.

What percentage of Neurocrine Biosciences (NBIX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 21.99% of Neurocrine Biosciences (NBIX) stock is held by institutional investors.

What percentage of Neurocrine Biosciences (NBIX) stock is held by retail investors?

According to the latest TipRanks data, approximately 20.48% of Neurocrine Biosciences (NBIX) stock is held by retail investors.

Who owns the most shares of Neurocrine Biosciences (NBIX)?

iShares owns the most shares of Neurocrine Biosciences (NBIX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.